MedinCell S.A.
MEDCL.PA · PAR
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €419 | €456 | €282 |
| - Cash | €19 | €59 | €32 | €19 |
| + Debt | €51 | €59 | €60 | €59 |
| Enterprise Value | – | €419 | €484 | €321 |
| Revenue | €12 | €16 | €9 | €4 |
| % Growth | -27.9% | 70.7% | 150.6% | – |
| Gross Profit | €0 | €16 | €9 | €3 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -€15 | -€4 | -€7 | -€12 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -€16 | -€4 | -€15 | -€17 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.49 | -0.12 | -0.5 | -0.58 |
| % Growth | -308.3% | 76% | 13.8% | – |
| Operating Cash Flow | -€14 | -€3 | €22 | -€0 |
| Capital Expenditures | -€0 | -€1 | -€0 | -€0 |
| Free Cash Flow | -€14 | -€3 | €21 | -€0 |